- 理想的成長型公司, 本業EPS的成長幅度會大於營收的成長幅度
- 營收到某個數字後, 本業EPS呈現不成比例的增加, 有可能是規模經濟的效應
- 如果是有淡旺季的公司, 是否有淡季不淡, 旺季更旺的情況
- 漲很多的股票要留意 EPS 較上季是否有大幅衰退的情況
- 如果EPS衰退，要觀察同業是不是有一樣的狀況
- 要留意增資減資和公司債對股本及EPS的影響
| 加權平均股數 QoQ YoY | EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | 營收 QoQ YoY | 毛利率(%) QoQ YoY | 營業利益率 QoQ YoY | 稅後淨利率 QoQ YoY | 營業利益 QoQ YoY | 稅後淨利 QoQ YoY | 稅前淨利率(%) QoQ YoY | 稅後淨利率(%) QoQ YoY | 兩季平均(YOY)營收成長率(%) | 兩季平均(YOY)EPS成長率(%) | 兩季平均(YOY)本業EPS成長率(%) | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24Q3 (20) | 47 | 6.82 | 6.82 | -0.05 | -155.56 | -200.0 | -0.06 | 0.0 | 33.33 | -0.09 | -125.0 | -113.24 | 0.56 | -6.67 | -6.67 | 32.80 | 24.57 | -5.94 | -6.50 | -2.52 | -340.74 | -3.57 | -168.26 | -144.46 | -0.04 | 0.0 | -300.0 | -0.02 | -150.0 | -200.0 | -4.15 | -173.98 | -133.47 | -3.57 | -168.26 | -144.46 | 27.74 | 6.83 | 35.72 |
| 24Q2 (19) | 44 | 0.0 | 0.0 | 0.09 | 169.23 | -89.29 | -0.06 | 71.43 | 73.91 | -0.04 | 69.23 | -106.35 | 0.6 | 62.16 | -6.25 | 26.33 | -5.9 | -42.81 | -6.34 | 76.31 | -262.98 | 5.23 | 137.93 | -93.26 | -0.04 | 60.0 | -300.0 | 0.04 | 166.67 | -89.19 | 5.61 | 136.93 | -92.87 | 5.23 | 137.93 | -93.26 | 15.98 | 132.00 | -26.08 |
| 24Q1 (18) | 44 | 0.0 | 0.0 | -0.13 | 94.78 | 38.1 | -0.21 | -123.6 | -90.91 | -0.13 | 92.82 | 38.1 | 0.37 | -30.19 | -30.19 | 27.98 | 44.82 | -2.68 | -26.76 | -81.42 | -256.32 | -13.79 | 95.35 | 4.63 | -0.1 | -25.0 | -150.0 | -0.06 | 94.55 | 33.33 | -15.19 | 94.95 | -7.81 | -13.79 | 95.35 | 4.63 | -20.93 | -2492.61 | 482.65 |
| 23Q4 (17) | 44 | 0.0 | 4.76 | -2.49 | -5080.0 | -536.84 | 0.89 | 1088.89 | 486.96 | -1.81 | -366.18 | -6133.33 | 0.53 | -11.67 | 178.95 | 19.32 | -44.59 | -61.8 | -14.75 | -646.3 | 51.21 | -296.62 | -3793.9 | -328.34 | -0.08 | -500.0 | -33.33 | -1.1 | -5600.0 | -558.33 | -300.61 | -2524.27 | -294.24 | -296.62 | -3793.9 | -328.34 | -8.96 | -2587.03 | 574.88 |
| 23Q3 (16) | 44 | 0.0 | 0.0 | 0.05 | -94.05 | -16.67 | -0.09 | 60.87 | 30.77 | 0.68 | 7.94 | 223.64 | 0.6 | -6.25 | 114.29 | 34.87 | -24.26 | -24.99 | 2.70 | -30.59 | 114.42 | 8.03 | -89.65 | -12.62 | 0.02 | 0.0 | 140.0 | 0.02 | -94.59 | -33.33 | 12.40 | -84.24 | -13.59 | 8.03 | -89.65 | -12.62 | 7.25 | 202.97 | -24.11 |
| 23Q2 (15) | 44 | 0.0 | 2.33 | 0.84 | 500.0 | 380.0 | -0.23 | -109.09 | -35.29 | 0.63 | 400.0 | 198.44 | 0.64 | 20.75 | 190.91 | 46.04 | 60.14 | 16.09 | 3.89 | 151.8 | 109.57 | 77.57 | 636.45 | 228.66 | 0.02 | 150.0 | 122.22 | 0.37 | 511.11 | 384.62 | 78.66 | 658.27 | 220.33 | 77.57 | 636.45 | 228.66 | 99.85 | 181.58 | -28.46 |
| 23Q1 (14) | 44 | 4.76 | 15.79 | -0.21 | -136.84 | 36.36 | -0.11 | 52.17 | -22.22 | -0.21 | -800.0 | 36.36 | 0.53 | 178.95 | 211.76 | 28.75 | -43.16 | -50.11 | -7.51 | 75.16 | 69.28 | -14.46 | -111.13 | 80.15 | -0.04 | 33.33 | 0.0 | -0.09 | -137.5 | 30.77 | -14.09 | -109.1 | 81.83 | -14.46 | -111.13 | 80.15 | 73.41 | 356.58 | -12.38 |
| 22Q4 (13) | 42 | -4.55 | 35.48 | 0.57 | 850.0 | 35.71 | -0.23 | -76.92 | -53.33 | 0.03 | 105.45 | -97.17 | 0.19 | -32.14 | -17.39 | 50.58 | 8.8 | -8.37 | -30.23 | -61.49 | -14.99 | 129.90 | 1313.49 | 134.43 | -0.06 | -20.0 | 0.0 | 0.24 | 700.0 | 84.62 | 154.76 | 978.47 | 159.84 | 129.90 | 1313.49 | 134.43 | -2.44 | 485.00 | -26.70 |
| 22Q3 (12) | 44 | 2.33 | 46.67 | 0.06 | 120.0 | -83.33 | -0.13 | 23.53 | -550.0 | -0.55 | 14.06 | -182.09 | 0.28 | 27.27 | 16.67 | 46.49 | 17.22 | 16.2 | -18.72 | 53.95 | -170.52 | 9.19 | 115.24 | -79.58 | -0.05 | 44.44 | -150.0 | 0.03 | 123.08 | -72.73 | 14.35 | 121.95 | -66.08 | 9.19 | 115.24 | -79.58 | 28.34 | 64.55 | -32.68 |
| 22Q2 (11) | 43 | 13.16 | 43.33 | -0.30 | 9.09 | -168.18 | -0.17 | -88.89 | -213.33 | -0.64 | -93.94 | -306.45 | 0.22 | 29.41 | -37.14 | 39.66 | -31.18 | -12.18 | -40.65 | -66.26 | -229.87 | -60.29 | 17.22 | -234.85 | -0.09 | -125.0 | -181.82 | -0.13 | 0.0 | -200.0 | -65.37 | 15.68 | -232.46 | -60.29 | 17.22 | -234.85 | 1.66 | -84.74 | -24.45 |
| 22Q1 (10) | 38 | 22.58 | 26.67 | -0.33 | -178.57 | -153.85 | -0.09 | 40.0 | -550.0 | -0.33 | -131.13 | -153.85 | 0.17 | -26.09 | -22.73 | 57.63 | 4.4 | -18.83 | -24.45 | 7.0 | -238.64 | -72.83 | -231.44 | -171.96 | -0.04 | 33.33 | -100.0 | -0.13 | -200.0 | -225.0 | -77.53 | -230.17 | -155.87 | -72.83 | -231.44 | -171.96 | -15.13 | -80.95 | -305.00 |
| 21Q4 (9) | 31 | 3.33 | 6.9 | 0.42 | 16.67 | 231.25 | -0.15 | -650.0 | -275.0 | 1.06 | 58.21 | 215.22 | 0.23 | -4.17 | -37.84 | 55.20 | 37.97 | -17.97 | -26.29 | -279.91 | -1321.08 | 55.41 | 23.11 | 353.59 | -0.06 | -200.0 | -500.0 | 0.13 | 18.18 | 244.44 | 59.56 | 40.77 | 376.12 | 55.41 | 23.11 | 353.59 | -17.80 | -0.75 | -381.67 |
| 21Q3 (8) | 30 | 0.0 | 3.45 | 0.36 | -18.18 | 238.46 | -0.02 | -113.33 | 81.82 | 0.67 | 116.13 | 211.67 | 0.24 | -31.43 | -38.46 | 40.01 | -11.4 | -46.28 | -6.92 | -122.11 | -28.86 | 45.01 | 0.67 | 580.36 | -0.02 | -118.18 | 0.0 | 0.11 | -15.38 | 237.5 | 42.31 | -14.27 | 454.95 | 45.01 | 0.67 | 580.36 | 13.83 | 210.14 | 268.33 |
| 21Q2 (7) | 30 | 0.0 | 3.45 | 0.44 | 438.46 | 276.0 | 0.15 | 650.0 | 178.95 | 0.31 | 338.46 | 191.18 | 0.35 | 59.09 | -14.63 | 45.16 | -36.39 | -28.78 | 31.30 | 533.52 | 306.46 | 44.71 | 266.95 | 491.51 | 0.11 | 650.0 | 283.33 | 0.13 | 425.0 | 285.71 | 49.35 | 262.87 | 558.22 | 44.71 | 266.95 | 491.51 | 9.28 | 248.92 | 400.00 |
| 21Q1 (6) | 30 | 3.45 | 3.45 | -0.13 | 59.38 | -44.44 | 0.02 | 150.0 | 150.0 | -0.13 | 85.87 | -44.44 | 0.22 | -40.54 | -15.38 | 71.00 | 5.51 | -5.46 | -7.22 | -290.27 | -389.96 | -26.78 | -22.56 | -744.79 | -0.02 | -100.0 | -300.0 | -0.04 | 55.56 | -33.33 | -30.30 | -40.47 | -6686.96 | -26.78 | -22.56 | -744.79 | -22.84 | 18.15 | 106.82 |
| 20Q4 (5) | 29 | 0.0 | 7.41 | -0.32 | -23.08 | -357.14 | -0.04 | 63.64 | 33.33 | -0.92 | -53.33 | -50.82 | 0.37 | -5.13 | 48.0 | 67.29 | -9.65 | -0.37 | -1.85 | 65.55 | -159.68 | -21.85 | -133.19 | -420.38 | -0.01 | 50.0 | -200.0 | -0.09 | -12.5 | -350.0 | -21.57 | -80.96 | -519.65 | -21.85 | -133.19 | -420.38 | - | - | 0.00 |
| 20Q3 (4) | 29 | 0.0 | 0.0 | -0.26 | -4.0 | 0.0 | -0.11 | 42.11 | 0.0 | -0.60 | -76.47 | 0.0 | 0.39 | -4.88 | 0.0 | 74.48 | 17.46 | 0.0 | -5.37 | 64.58 | 0.0 | -9.37 | 17.95 | 0.0 | -0.02 | 66.67 | 0.0 | -0.08 | -14.29 | 0.0 | -11.92 | -10.68 | 0.0 | -9.37 | 17.95 | 0.0 | - | - | 0.00 |
| 20Q2 (3) | 29 | 0.0 | 0.0 | -0.25 | -177.78 | 0.0 | -0.19 | -375.0 | 0.0 | -0.34 | -277.78 | 0.0 | 0.41 | 57.69 | 0.0 | 63.41 | -15.57 | 0.0 | -15.16 | -708.84 | 0.0 | -11.42 | -260.25 | 0.0 | -0.06 | -700.0 | 0.0 | -0.07 | -133.33 | 0.0 | -10.77 | -2441.3 | 0.0 | -11.42 | -260.25 | 0.0 | - | - | 0.00 |
| 20Q1 (2) | 29 | 7.41 | 0.0 | -0.09 | -28.57 | 0.0 | -0.04 | 33.33 | 0.0 | -0.09 | 85.25 | 0.0 | 0.26 | 4.0 | 0.0 | 75.10 | 11.19 | 0.0 | 2.49 | -19.68 | 0.0 | -3.17 | -146.48 | 0.0 | 0.01 | 0.0 | 0.0 | -0.03 | -50.0 | 0.0 | 0.46 | -91.05 | 0.0 | -3.17 | -146.48 | 0.0 | - | - | 0.00 |
| 19Q4 (1) | 27 | 0.0 | 0.0 | -0.07 | 0.0 | 0.0 | -0.06 | 0.0 | 0.0 | -0.61 | 0.0 | 0.0 | 0.25 | 0.0 | 0.0 | 67.54 | 0.0 | 0.0 | 3.10 | 0.0 | 0.0 | 6.82 | 0.0 | 0.0 | 0.01 | 0.0 | 0.0 | -0.02 | 0.0 | 0.0 | 5.14 | 0.0 | 0.0 | 6.82 | 0.0 | 0.0 | - | - | 0.00 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/10 | 0.12 | -43.65 | -8.72 | 1.65 | -13.51 | 0.48 | N/A | - | ||
| 2024/9 | 0.21 | 40.77 | 2.95 | 1.53 | -13.86 | 0.56 | 0.38 | - | ||
| 2024/8 | 0.15 | -23.94 | -31.89 | 1.32 | -16.05 | 0.56 | 0.37 | - | ||
| 2024/7 | 0.2 | -9.07 | 9.44 | 1.17 | -13.48 | 0.62 | 0.34 | - | ||
| 2024/6 | 0.22 | 7.1 | 61.81 | 0.97 | -17.0 | 0.6 | 0.35 | 因本公司本月訂單增加及子公司收入增加,故比去年同期收入增加. | ||
| 2024/5 | 0.2 | 9.3 | -18.36 | 0.76 | -27.14 | 0.57 | 0.37 | - | ||
| 2024/4 | 0.18 | 1.18 | -25.07 | 0.56 | -29.89 | 0.42 | 0.5 | - | ||
| 2024/3 | 0.18 | 267.32 | -38.2 | 0.37 | -32.08 | 0.37 | 0.62 | - | ||
| 2024/2 | 0.05 | -63.78 | -74.33 | 0.19 | -24.8 | 0.38 | 0.6 | 因遇春節連假,交易日減少,故收入比去年同期減少 | ||
| 2024/1 | 0.14 | -29.03 | 149.69 | 0.14 | 149.69 | 0.54 | 0.43 | 因本期增加合併子公司營收，故比去年同期增加 | ||
| 2023/12 | 0.19 | -7.58 | 133.7 | 2.31 | 171.36 | 0.53 | 0.43 | 因本期增加合併子公司營收,故比去年同期增加 | ||
| 2023/11 | 0.21 | 60.99 | 329.93 | 2.12 | 175.42 | 0.54 | 0.42 | 因本期增加合併子公司營收,故比去年同期增加 | ||
| 2023/10 | 0.13 | -36.43 | 135.83 | 1.91 | 164.96 | 0.55 | 0.41 | 因本期增加合併子公司營收,故比去年同期增加 | ||
| 2023/9 | 0.2 | -6.86 | 315.88 | 1.78 | 167.38 | 0.6 | 0.31 | 因本期增加合併子公司營收,故比去年同期增加 | ||
| 2023/8 | 0.22 | 22.2 | 180.06 | 1.57 | 155.5 | 0.53 | 0.36 | 因本期增加合併子公司營收,故比去年同期增加 | ||
| 2023/7 | 0.18 | 34.43 | 20.46 | 1.35 | 151.91 | 0.56 | 0.34 | 因本期增加合併子公司營收,故比去年同期增加 | ||
| 2023/6 | 0.13 | -45.96 | 44.22 | 1.17 | 202.54 | 0.63 | 0.29 | 因本期增加合併子公司營收,故比去年同期增加 | ||
| 2023/5 | 0.25 | 0.32 | 191.26 | 1.04 | 252.34 | 0.79 | 0.23 | 因本期增加合併子公司營收,故比去年同期增加 | ||
| 2023/4 | 0.25 | -16.54 | 551.57 | 0.79 | 277.08 | 0.74 | 0.24 | 因本期增加合併子公司營收,故比去年同期增加 | ||
| 2023/3 | 0.3 | 52.55 | 423.33 | 0.54 | 216.63 | 0.54 | 0.39 | 因本期增加合併子公司營收,故比去年用期增加 | ||
| 2023/2 | 0.19 | 252.32 | 267.62 | 0.25 | 115.49 | 0.33 | 0.63 | 因本期增加合併子公司營收，故比去年同期增加 | ||
| 2023/1 | 0.06 | -33.57 | -12.32 | 0.06 | -12.32 | 0.19 | 1.13 | - | ||
| 2022/12 | 0.08 | 70.0 | -12.27 | 0.85 | -17.96 | 0.19 | 0.21 | - | ||
| 2022/11 | 0.05 | -11.68 | 3.96 | 0.77 | -18.53 | 0.15 | 0.26 | - | ||
| 2022/10 | 0.06 | 12.08 | -38.7 | 0.72 | -19.7 | 0.18 | 0.22 | - | ||
| 2022/9 | 0.05 | -37.28 | -4.7 | 0.66 | -17.58 | 0.28 | 0.18 | - | ||
| 2022/8 | 0.08 | -47.43 | -0.88 | 0.62 | -18.46 | 0.32 | 0.16 | - | ||
| 2022/7 | 0.15 | 60.94 | 43.29 | 0.54 | -20.52 | 0.33 | 0.15 | - | ||
| 2022/6 | 0.09 | 9.12 | -38.35 | 0.39 | -32.16 | 0.22 | 0.19 | - | ||
| 2022/5 | 0.09 | 124.43 | -20.77 | 0.29 | -29.94 | 0.18 | 0.22 | - | ||
| 2022/4 | 0.04 | -32.97 | -59.39 | 0.21 | -33.08 | 0.15 | 0.27 | 因疫情影響,進口藥物交期延宕所致 | ||
| 2022/3 | 0.06 | 7.16 | -37.63 | 0.17 | -21.95 | 0.17 | 0.12 | - | ||
| 2022/2 | 0.05 | -15.97 | -13.79 | 0.12 | -11.0 | 0.21 | 0.1 | - | ||
| 2022/1 | 0.06 | -33.53 | -8.52 | 0.06 | -8.52 | 0.2 | 0.1 | - | ||
| 2021/12 | 0.09 | 101.47 | -31.41 | 1.04 | -24.69 | 0.23 | 0.13 | - | ||
| 2021/11 | 0.05 | -47.93 | -56.92 | 0.94 | -23.94 | 0.19 | 0.16 | 因減少合併子公司故本月營收較同期減少 | ||
| 2021/10 | 0.09 | 74.25 | -27.49 | 0.9 | -20.77 | 0.22 | 0.14 | - | ||
| 2021/9 | 0.05 | -34.76 | -54.66 | 0.81 | -19.94 | 0.24 | 0.21 | 因減少合併子公司故本月營收較同期減少 | ||
| 2021/8 | 0.08 | -24.0 | -42.13 | 0.76 | -15.51 | 0.33 | 0.15 | - | ||
| 2021/7 | 0.1 | -30.76 | -24.15 | 0.68 | -10.7 | 0.36 | 0.14 | - | ||
| 2021/6 | 0.15 | 40.25 | 60.17 | 0.57 | -7.79 | 0.35 | 0.28 | 本月營收:西藥3,743;試劑8,630;租金收入1,034;售電收入697;其他951 | ||
| 2021/5 | 0.11 | 15.03 | -31.43 | 0.42 | -19.94 | 0.29 | 0.34 | - | ||
| 2021/4 | 0.09 | 2.94 | -17.7 | 0.31 | -15.07 | 0.25 | 0.41 | - | ||
| 2021/3 | 0.09 | 48.12 | -18.83 | 0.22 | -13.9 | 0.22 | 0.18 | - | ||
| 2021/2 | 0.06 | -10.84 | -21.66 | 0.13 | -10.09 | 0.27 | 0.15 | - | ||
| 2021/1 | 0.07 | -50.16 | 4.33 | 0.07 | 4.33 | 0.32 | 0.13 | 本月營收:西藥2,954;租金收入3,270;售電收入639 | ||
| 2020/12 | 0.14 | 26.52 | -22.19 | 1.38 | 117.18 | 0.37 | 0.13 | 本月營收:西藥2,959;租金收入3,005;售電收入512;顧問收入7,295 | ||
| 2020/11 | 0.11 | -12.36 | 177.79 | 1.24 | 171.09 | 0.35 | 0.14 | 因合併子公司,故本月營收較去年同期增加.本月營收:西藥3,694;租金收入3,088;售電收入592;顧問收入3,510 | ||
| 2020/10 | 0.12 | 8.95 | 281.88 | 1.13 | 170.46 | 0.38 | 0.13 | 因合併子公司,故本月營收較去年同期增加.本月營收:西藥7,919;租金收入2,742;售電收入806;顧問收入952 | ||
| 2020/9 | 0.11 | -16.73 | 235.03 | 1.01 | 161.07 | 0.39 | 0.13 | 因合併子公司,故本月營收較去年同期增加.本月營收:西藥2,785;租金收入2,864;售電收入878;顧問收入4,871 | ||
| 2020/8 | 0.14 | -0.39 | 247.34 | 0.89 | 153.92 | 0.37 | 0.14 | 因合併子公司,故本月營收較去年同期增加.本月營收:西藥4,472;租金收入2,764;售電收入738;其他-口罩286;顧問收入5,429 | ||
| 2020/7 | 0.14 | 46.21 | 241.61 | 0.76 | 142.14 | 0.39 | 0.13 | 因合併子公司,故本月營收較去年同期增加.本月營收:西藥4,931;租金收入1,827;售電收入966;顧問收入6,019 | ||
| 2020/6 | 0.09 | -39.96 | 130.31 | 0.62 | 127.64 | 0.36 | 0.19 | 因合併子公司營收,故本月營收較去年同期增加.本月營收:西藥3,660;租金收入2,021;售電收入885;顧問收入2,833 | ||
| 2020/5 | 0.16 | 38.08 | 326.01 | 0.53 | 127.17 | 0.38 | 0.18 | 因合併子公司營收,故本月營收較去年同期增加.本月營收:西藥3,373;租金收入2,352;售電收入517;顧問收入9,414 | ||
| 2020/4 | 0.11 | 1.52 | 669.19 | 0.37 | 89.65 | 0.3 | 0.23 | 因合併子公司營收,故本月營收較去年同期大幅增加.本月營收:西藥1,909;租金收入2,049;售電收入818;顧問收入6,562 | ||
| 2020/3 | 0.11 | 42.97 | 128.99 | 0.26 | 42.21 | 0.26 | 0.35 | 因合併子公司營收,故本月營收較去年同期營收增加。本月營收:西藥3,592;租金收入1,758;售電收入756;顧問收入5,062 | ||
| 2020/2 | 0.08 | 18.74 | 163.79 | 0.14 | 9.97 | 0.32 | 0.28 | 因合併子公司營收,故本月營收較去年同期營收增加,本月營收：西藥2,488;租金收入1,467;售電收入713;顧問收入3,143 | ||
| 2020/1 | 0.07 | -62.83 | -35.3 | 0.07 | -35.3 | 0.28 | 0.32 | 本月營收:西藥2,604;租金收入1,980;售電收入720;顧問收入1,274 | ||
| 2019/12 | 0.18 | 351.76 | 486.28 | 0.63 | 18.16 | 0.0 | N/A | 除本月業績增加外,另因合併子公司營收,故108年12月營收增加 | ||
| 2019/11 | 0.04 | 20.47 | 20.85 | 0.46 | -9.71 | 0.0 | N/A | - |
| 加權平均股數 YoY | EPS YoY | 本業EPS YoY | 營收 YoY | 毛利率(%) YoY | 營業利益率 YoY | 稅後淨利率 YoY | 營業利益 YoY | 稅前淨利 YoY | 稅後淨利 YoY | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | 44 | 4.76 | -1.81 | 0 | 0.47 | 0 | 2.31 | 171.76 | 32.97 | -31.18 | -3.35 | 0 | -48.19 | 0 | -0.08 | 0 | -1.1 | 0 | -0.8 | 0 |
| 2022 (9) | 42 | 35.48 | 0.03 | -97.17 | -0.60 | 0 | 0.85 | -18.27 | 47.91 | -7.37 | -27.96 | 0 | 1.50 | -95.31 | -0.24 | 0 | 0.05 | -85.29 | 0.01 | -96.88 |
| 2021 (8) | 31 | 6.9 | 1.06 | 0 | -0.02 | 0 | 1.04 | -24.64 | 51.72 | -27.77 | 1.63 | 0 | 31.98 | 0 | 0.02 | 0 | 0.34 | 0 | 0.32 | 0 |
| 2020 (7) | 29 | 7.41 | -0.92 | 0 | -0.38 | 0 | 1.38 | 119.05 | 71.60 | 57.26 | -6.06 | 0 | -12.50 | 0 | -0.08 | 0 | -0.17 | 0 | -0.27 | 0 |
| 2019 (6) | 27 | 0.0 | -0.61 | 0 | -0.34 | 0 | 0.63 | 16.67 | 45.53 | 191.67 | -24.91 | 0 | -20.07 | 0 | -0.16 | 0 | -0.16 | 0 | -0.16 | 0 |
| 2018 (5) | 27 | 0.0 | -0.88 | 0 | -0.55 | 0 | 0.54 | -37.21 | 15.61 | -2.74 | -49.67 | 0 | -43.66 | 0 | -0.27 | 0 | -0.23 | 0 | -0.23 | 0 |
| 2017 (4) | 27 | 0.0 | -0.39 | 0 | -0.45 | 0 | 0.86 | -51.96 | 16.05 | -42.41 | -16.22 | 0 | -12.02 | 0 | -0.14 | 0 | -0.03 | 0 | -0.1 | 0 |
| 2016 (3) | 27 | 0.0 | 0.08 | 0 | -0.02 | 0 | 1.79 | -26.94 | 27.87 | -6.57 | 2.08 | 128.57 | -2.30 | 0 | 0.04 | 100.0 | 0.06 | -40.0 | 0.02 | 0 |
| 2015 (2) | 27 | 0.0 | -0.13 | 0 | -0.23 | 0 | 2.45 | -18.33 | 29.83 | 10.73 | 0.91 | 0 | -1.59 | 0 | 0.02 | 0 | 0.1 | -47.37 | -0.03 | 0 |
| 2014 (1) | 27 | 0.0 | 0.57 | 0 | -0.19 | 0 | 3.0 | -61.83 | 26.94 | 0 | -1.70 | 0 | -3.27 | 0 | -0.05 | 0 | 0.19 | 0 | 0.15 | 0 |
